APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Nuclear Receptor ROR-Gamma

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Nuclear Receptor ROR-Gamma Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025197 pages

Choose your research edition.

Industry ResearchNuclear Receptor ROR-Gamma Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Nuclear Receptor ROR-Gamma Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Nuclear Receptor ROR-Gamma Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nuclear Receptor ROR-Gamma Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Nuclear Receptor ROR-Gamma Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Nuclear Receptor ROR-Gamma market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Nuclear Receptor ROR-Gamma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nuclear Receptor ROR-Gamma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nuclear Receptor ROR-Gamma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Nuclear Receptor ROR-Gamma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nuclear Receptor ROR-Gamma include 4SC AG, Vitae Pharmaceuticals, Inc., Visionary Pharmaceuticals, Inc., Teijin Pharma Limited, Reata Pharmaceuticals, Inc., Phenex Pharmaceuticals AG, Nuevolution AB, Lead Pharma Holding B.V. and Karo Bio AB, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Nuclear Receptor ROR-Gamma market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nuclear Receptor ROR-Gamma and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nuclear Receptor ROR-Gamma revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Nuclear Receptor ROR-Gamma market size, projected growth trends, production technologies, key applications, and end-use industries.

Nuclear Receptor ROR-Gamma Segment by Company

4SC AG

Vitae Pharmaceuticals, Inc.

Visionary Pharmaceuticals, Inc.

Teijin Pharma Limited

Reata Pharmaceuticals, Inc.

Phenex Pharmaceuticals AG

Nuevolution AB

Lead Pharma Holding B.V.

Karo Bio AB

Hanmi Pharmaceuticals, Co. Ltd.

GlaxoSmithKline Plc

Genfit SA

Genentech, Inc.

Celgene Corporation

Bristol-Myers Squibb Company

Brickell Biotech, Inc.

Biogen, Inc.

Aurigene Discovery Technologies Limited

Arrien Pharmaceuticals, LLC

Advinus Therapeutics Ltd.

Nuclear Receptor ROR-Gamma Segment by Type

BBI-6000

GSK-2981278

INV-17

VPR-66

Others

Nuclear Receptor ROR-Gamma Segment by Application

Hospital

Clinic

Others

Nuclear Receptor ROR-Gamma Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nuclear Receptor ROR-Gamma market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nuclear Receptor ROR-Gamma and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nuclear Receptor ROR-Gamma.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Nuclear Receptor ROR-Gamma in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nuclear Receptor ROR-Gamma industry.

Chapter 3: Detailed analysis of Nuclear Receptor ROR-Gamma companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nuclear Receptor ROR-Gammarevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nuclear Receptor ROR-Gamma Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of BBI-6000 Table 3. Key Players of GSK-2981278 Table 4. Key Players of INV-17 Table 3. Key Players of VPR-66 Table 4. Key Players of Others Table 5. Global Nuclear Receptor ROR-Gamma Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Hospital Table 7. Key Players of Clinic Table 8. Key Players of Others Table 9. Global Nuclear Receptor ROR-Gamma Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Nuclear Receptor ROR-Gamma Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Nuclear Receptor ROR-Gamma Market Share by Region (2021-2026) Table 12. Global Nuclear Receptor ROR-Gamma Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Nuclear Receptor ROR-Gamma Market Share by Region (2027-2032) Table 14. Nuclear Receptor ROR-Gamma Industry Trends Table 15. Nuclear Receptor ROR-Gamma Industry Drivers Table 16. Nuclear Receptor ROR-Gamma Industry Opportunities and Challenges Table 17. Nuclear Receptor ROR-Gamma Industry Restraints Table 18. Global Nuclear Receptor ROR-Gamma Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Company (2021-2026) Table 20. Global Nuclear Receptor ROR-Gamma Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Nuclear Receptor ROR-Gamma Key Company Head Office and Area Served Table 22. Global Nuclear Receptor ROR-Gamma Company, Product Type & Application Table 23. Global Nuclear Receptor ROR-Gamma Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Nuclear Receptor ROR-Gamma by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Nuclear Receptor ROR-Gamma Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Nuclear Receptor ROR-Gamma Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Nuclear Receptor ROR-Gamma Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Type (2021-2026) Table 30. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Type (2027-2032) Table 31. Global Nuclear Receptor ROR-Gamma Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Nuclear Receptor ROR-Gamma Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Nuclear Receptor ROR-Gamma Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Application (2021-2026) Table 35. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Application (2027-2032) Table 36. 4SC AG Company Information Table 37. 4SC AG Business Overview Table 38. 4SC AG Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. 4SC AG Nuclear Receptor ROR-Gamma Product Portfolio Table 40. 4SC AG Recent Development Table 41. Vitae Pharmaceuticals, Inc. Company Information Table 42. Vitae Pharmaceuticals, Inc. Business Overview Table 43. Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product Portfolio Table 45. Vitae Pharmaceuticals, Inc. Recent Development Table 46. Visionary Pharmaceuticals, Inc. Company Information Table 47. Visionary Pharmaceuticals, Inc. Business Overview Table 48. Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product Portfolio Table 50. Visionary Pharmaceuticals, Inc. Recent Development Table 51. Teijin Pharma Limited Company Information Table 52. Teijin Pharma Limited Business Overview Table 53. Teijin Pharma Limited Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Teijin Pharma Limited Nuclear Receptor ROR-Gamma Product Portfolio Table 55. Teijin Pharma Limited Recent Development Table 56. Reata Pharmaceuticals, Inc. Company Information Table 57. Reata Pharmaceuticals, Inc. Business Overview Table 58. Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product Portfolio Table 60. Reata Pharmaceuticals, Inc. Recent Development Table 61. Phenex Pharmaceuticals AG Company Information Table 62. Phenex Pharmaceuticals AG Business Overview Table 63. Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Product Portfolio Table 65. Phenex Pharmaceuticals AG Recent Development Table 66. Nuevolution AB Company Information Table 67. Nuevolution AB Business Overview Table 68. Nuevolution AB Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Nuevolution AB Nuclear Receptor ROR-Gamma Product Portfolio Table 70. Nuevolution AB Recent Development Table 71. Lead Pharma Holding B.V. Company Information Table 72. Lead Pharma Holding B.V. Business Overview Table 73. Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Product Portfolio Table 75. Lead Pharma Holding B.V. Recent Development Table 76. Karo Bio AB Company Information Table 77. Karo Bio AB Business Overview Table 78. Karo Bio AB Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Karo Bio AB Nuclear Receptor ROR-Gamma Product Portfolio Table 80. Karo Bio AB Recent Development Table 81. Hanmi Pharmaceuticals, Co. Ltd. Company Information Table 82. Hanmi Pharmaceuticals, Co. Ltd. Business Overview Table 83. Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Product Portfolio Table 85. Hanmi Pharmaceuticals, Co. Ltd. Recent Development Table 86. GlaxoSmithKline Plc Company Information Table 87. GlaxoSmithKline Plc Business Overview Table 88. GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Product Portfolio Table 90. GlaxoSmithKline Plc Recent Development Table 91. Genfit SA Company Information Table 92. Genfit SA Business Overview Table 93. Genfit SA Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. Genfit SA Nuclear Receptor ROR-Gamma Product Portfolio Table 95. Genfit SA Recent Development Table 96. Genentech, Inc. Company Information Table 97. Genentech, Inc. Business Overview Table 98. Genentech, Inc. Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. Genentech, Inc. Nuclear Receptor ROR-Gamma Product Portfolio Table 100. Genentech, Inc. Recent Development Table 101. Celgene Corporation Company Information Table 102. Celgene Corporation Business Overview Table 103. Celgene Corporation Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. Celgene Corporation Nuclear Receptor ROR-Gamma Product Portfolio Table 105. Celgene Corporation Recent Development Table 106. Bristol-Myers Squibb Company Company Information Table 107. Bristol-Myers Squibb Company Business Overview Table 108. Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Product Portfolio Table 110. Bristol-Myers Squibb Company Recent Development Table 111. Brickell Biotech, Inc. Company Information Table 112. Brickell Biotech, Inc. Business Overview Table 113. Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 114. Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Product Portfolio Table 115. Brickell Biotech, Inc. Recent Development Table 116. Biogen, Inc. Company Information Table 117. Biogen, Inc. Business Overview Table 118. Biogen, Inc. Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 119. Biogen, Inc. Nuclear Receptor ROR-Gamma Product Portfolio Table 120. Biogen, Inc. Recent Development Table 121. Aurigene Discovery Technologies Limited Company Information Table 122. Aurigene Discovery Technologies Limited Business Overview Table 123. Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 124. Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Product Portfolio Table 125. Aurigene Discovery Technologies Limited Recent Development Table 126. Arrien Pharmaceuticals, LLC Company Information Table 127. Arrien Pharmaceuticals, LLC Business Overview Table 128. Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 129. Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Product Portfolio Table 130. Arrien Pharmaceuticals, LLC Recent Development Table 131. Advinus Therapeutics Ltd. Company Information Table 132. Advinus Therapeutics Ltd. Business Overview Table 133. Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 134. Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Product Portfolio Table 135. Advinus Therapeutics Ltd. Recent Development Table 136. North America Nuclear Receptor ROR-Gamma Market Size by Type (2021-2026) & (US$ Million) Table 137. North America Nuclear Receptor ROR-Gamma Market Size by Type (2027-2032) & (US$ Million) Table 138. North America Nuclear Receptor ROR-Gamma Market Size by Application (2021-2026) & (US$ Million) Table 139. North America Nuclear Receptor ROR-Gamma Market Size by Application (2027-2032) & (US$ Million) Table 140. North America Nuclear Receptor ROR-Gamma Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. North America Nuclear Receptor ROR-Gamma Market Size by Country (2021-2026) Table 142. North America Nuclear Receptor ROR-Gamma Market Size by Country (2027-2032) Table 143. Europe Nuclear Receptor ROR-Gamma Market Size by Type (2021-2026) & (US$ Million) Table 144. Europe Nuclear Receptor ROR-Gamma Market Size by Type (2027-2032) & (US$ Million) Table 145. Europe Nuclear Receptor ROR-Gamma Market Size by Application (2021-2026) & (US$ Million) Table 146. Europe Nuclear Receptor ROR-Gamma Market Size by Application (2027-2032) & (US$ Million) Table 147. Europe Nuclear Receptor ROR-Gamma Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Europe Nuclear Receptor ROR-Gamma Market Size by Country (2021-2026) Table 149. Europe Nuclear Receptor ROR-Gamma Market Size by Country (2027-2032) Table 150. China Nuclear Receptor ROR-Gamma Market Size by Type (2021-2026) & (US$ Million) Table 151. China Nuclear Receptor ROR-Gamma Market Size by Type (2027-2032) & (US$ Million) Table 152. China Nuclear Receptor ROR-Gamma Market Size by Application (2021-2026) & (US$ Million) Table 153. China Nuclear Receptor ROR-Gamma Market Size by Application (2027-2032) & (US$ Million) Table 154. Asia Nuclear Receptor ROR-Gamma Market Size by Type (2021-2026) & (US$ Million) Table 155. Asia Nuclear Receptor ROR-Gamma Market Size by Type (2027-2032) & (US$ Million) Table 156. Asia Nuclear Receptor ROR-Gamma Market Size by Application (2021-2026) & (US$ Million) Table 157. Asia Nuclear Receptor ROR-Gamma Market Size by Application (2027-2032) & (US$ Million) Table 158. Asia Nuclear Receptor ROR-Gamma Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Asia Nuclear Receptor ROR-Gamma Market Size by Country (2021-2026) Table 160. Asia Nuclear Receptor ROR-Gamma Market Size by Country (2027-2032) Table 161. South America, Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Type (2021-2026) & (US$ Million) Table 162. South America, Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Type (2027-2032) & (US$ Million) Table 163. South America, Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Application (2021-2026) & (US$ Million) Table 164. South America, Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Application (2027-2032) & (US$ Million) Table 165. South America, Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 166. South America, Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Country (2021-2026) Table 167. South America, Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Country (2027-2032) Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. Nuclear Receptor ROR-Gamma Product Image Figure 2. Global Nuclear Receptor ROR-Gamma Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Nuclear Receptor ROR-Gamma Market Share by Type: 2025 VS 2032 Figure 4. BBI-6000 Image Figure 5. GSK-2981278 Image Figure 6. INV-17 Image Figure 7. VPR-66 Image Figure 8. Others Image Figure 9. Global Nuclear Receptor ROR-Gamma Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Nuclear Receptor ROR-Gamma Market Share by Application: 2025 VS 2032 Figure 11. Hospital Image Figure 12. Clinic Image Figure 13. Others Image Figure 14. Global Nuclear Receptor ROR-Gamma Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Nuclear Receptor ROR-Gamma Market Size (2021-2032) & (US$ Million) Figure 16. Global Nuclear Receptor ROR-Gamma Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Nuclear Receptor ROR-Gamma Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Nuclear Receptor ROR-Gamma Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Nuclear Receptor ROR-Gamma Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Type (2021-2032) Figure 23. Global Nuclear Receptor ROR-Gamma Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Application (2021-2032) Figure 25. North America Nuclear Receptor ROR-Gamma Market Size (2021-2032) & (US$ Million) Figure 26. North America Nuclear Receptor ROR-Gamma Market Share by Type (2021-2032) Figure 27. North America Nuclear Receptor ROR-Gamma Market Share by Application (2021-2032) Figure 28. North America Nuclear Receptor ROR-Gamma Market Share by Country (2021-2032) Figure 29. United States Nuclear Receptor ROR-Gamma Market Size (2021-2032) & (US$ Million) Figure 30. Canada Nuclear Receptor ROR-Gamma Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Nuclear Receptor ROR-Gamma Market Size (2021-2032) & (US$ Million) Figure 32. Europe Nuclear Receptor ROR-Gamma Market Size (2021-2032) & (US$ Million) Figure 33. Europe Nuclear Receptor ROR-Gamma Market Share by Type (2021-2032) Figure 34. Europe Nuclear Receptor ROR-Gamma Market Share by Application (2021-2032) Figure 35. Europe Nuclear Receptor ROR-Gamma Market Share by Country (2021-2032) Figure 36. Germany Nuclear Receptor ROR-Gamma Market Size (2021-2032) & (US$ Million) Figure 37. France Nuclear Receptor ROR-Gamma Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Nuclear Receptor ROR-Gamma Market Size (2021-2032) & (US$ Million) Figure 39. Italy Nuclear Receptor ROR-Gamma Market Size (2021-2032) & (US$ Million) Figure 40. Russia Nuclear Receptor ROR-Gamma Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Nuclear Receptor ROR-Gamma Market Size (2021-2032) & (US$ Million) Figure 42. China Nuclear Receptor ROR-Gamma Market Size (2021-2032) & (US$ Million) Figure 43. China Nuclear Receptor ROR-Gamma Market Share by Type (2021-2032) Figure 44. China Nuclear Receptor ROR-Gamma Market Share by Application (2021-2032) Figure 45. Asia Nuclear Receptor ROR-Gamma Market Size (2021-2032) & (US$ Million) Figure 46. Asia Nuclear Receptor ROR-Gamma Market Share by Type (2021-2032) Figure 47. Asia Nuclear Receptor ROR-Gamma Market Share by Application (2021-2032) Figure 48. Asia Nuclear Receptor ROR-Gamma Market Share by Country (2021-2032) Figure 49. Japan Nuclear Receptor ROR-Gamma Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Nuclear Receptor ROR-Gamma Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Nuclear Receptor ROR-Gamma Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Nuclear Receptor ROR-Gamma Market Size (2021-2032) & (US$ Million) Figure 53. India Nuclear Receptor ROR-Gamma Market Size (2021-2032) & (US$ Million) Figure 54. Australia Nuclear Receptor ROR-Gamma Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Nuclear Receptor ROR-Gamma Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Nuclear Receptor ROR-Gamma Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Nuclear Receptor ROR-Gamma Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Nuclear Receptor ROR-Gamma Market Share by Country (2021-2032) Figure 59. Brazil Nuclear Receptor ROR-Gamma Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Nuclear Receptor ROR-Gamma Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Nuclear Receptor ROR-Gamma Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Nuclear Receptor ROR-Gamma Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Nuclear Receptor ROR-Gamma Market Size (2021-2032) & (US$ Million) Figure 64. UAE Nuclear Receptor ROR-Gamma Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Nuclear Receptor ROR-Gamma Market Size (2021-2032) & (US$ Million) Figure 66. Chile Nuclear Receptor ROR-Gamma Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • BBI-6000
  • GSK-2981278
  • INV-17
  • VPR-66
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • 4SC AG
  • Vitae Pharmaceuticals, Inc.
  • Visionary Pharmaceuticals, Inc.
  • Teijin Pharma Limited
  • Reata Pharmaceuticals, Inc.
  • Phenex Pharmaceuticals AG
  • Nuevolution AB
  • Lead Pharma Holding B.V.
  • Karo Bio AB
  • Hanmi Pharmaceuticals, Co. Ltd.
  • GlaxoSmithKline Plc
  • Genfit SA
  • Genentech, Inc.
  • Celgene Corporation
  • Bristol-Myers Squibb Company
  • Brickell Biotech, Inc.
  • Biogen, Inc.
  • Aurigene Discovery Technologies Limited
  • Arrien Pharmaceuticals, LLC
  • Advinus Therapeutics Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Nuclear Receptor ROR-Gamma Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 BBI-6000
  5. 1.2.3 GSK-2981278
  6. 1.2.4 INV-17
  7. 1.2.5 VPR-66
  8. 1.2.6 Others
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Nuclear Receptor ROR-Gamma Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Hospital
  12. 1.3.3 Clinic
  13. 1.3.4 Others
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Nuclear Receptor ROR-Gamma Growth Trends by Region
  16. 1.5.1 Global Nuclear Receptor ROR-Gamma Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Nuclear Receptor ROR-Gamma Market Size by Region (2021-2026)
  18. 1.5.3 Nuclear Receptor ROR-Gamma Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Nuclear Receptor ROR-Gamma Market Dynamics
  1. 2.1 Nuclear Receptor ROR-Gamma Industry Trends
  2. 2.2 Nuclear Receptor ROR-Gamma Industry Drivers
  3. 2.3 Nuclear Receptor ROR-Gamma Industry Opportunities and Challenges
  4. 2.4 Nuclear Receptor ROR-Gamma Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Nuclear Receptor ROR-Gamma Revenue by Company (2021-2026)
  2. 3.2 Global Nuclear Receptor ROR-Gamma Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Nuclear Receptor ROR-Gamma Key Company Head office and Area Served
  4. 3.4 Global Nuclear Receptor ROR-Gamma Company, Product Type & Application
  5. 3.5 Global Nuclear Receptor ROR-Gamma Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Nuclear Receptor ROR-Gamma Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Nuclear Receptor ROR-Gamma Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Nuclear Receptor ROR-Gamma Tier 1, Tier 2, and Tier 3
4 Nuclear Receptor ROR-Gamma Market by Type
  1. 4.1 Global Nuclear Receptor ROR-Gamma Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Nuclear Receptor ROR-Gamma Market Size by Type (2021-2032)
  3. 4.3 Global Nuclear Receptor ROR-Gamma Market Size Share by Type (2021-2032)
5 Nuclear Receptor ROR-Gamma Market by Application
  1. 5.1 Global Nuclear Receptor ROR-Gamma Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Nuclear Receptor ROR-Gamma Market Size by Application (2021-2032)
  3. 5.3 Global Nuclear Receptor ROR-Gamma Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 4SC AG
  2. 6.1.1 4SC AG Company Information
  3. 6.1.2 4SC AG Business Overview
  4. 6.1.3 4SC AG Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 4SC AG Nuclear Receptor ROR-Gamma Product Portfolio
  6. 6.1.5 4SC AG Recent Developments
  7. 6.2 Vitae Pharmaceuticals, Inc.
  8. 6.2.1 Vitae Pharmaceuticals, Inc. Company Information
  9. 6.2.2 Vitae Pharmaceuticals, Inc. Business Overview
  10. 6.2.3 Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product Portfolio
  12. 6.2.5 Vitae Pharmaceuticals, Inc. Recent Developments
  13. 6.3 Visionary Pharmaceuticals, Inc.
  14. 6.3.1 Visionary Pharmaceuticals, Inc. Company Information
  15. 6.3.2 Visionary Pharmaceuticals, Inc. Business Overview
  16. 6.3.3 Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product Portfolio
  18. 6.3.5 Visionary Pharmaceuticals, Inc. Recent Developments
  19. 6.4 Teijin Pharma Limited
  20. 6.4.1 Teijin Pharma Limited Company Information
  21. 6.4.2 Teijin Pharma Limited Business Overview
  22. 6.4.3 Teijin Pharma Limited Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Teijin Pharma Limited Nuclear Receptor ROR-Gamma Product Portfolio
  24. 6.4.5 Teijin Pharma Limited Recent Developments
  25. 6.5 Reata Pharmaceuticals, Inc.
  26. 6.5.1 Reata Pharmaceuticals, Inc. Company Information
  27. 6.5.2 Reata Pharmaceuticals, Inc. Business Overview
  28. 6.5.3 Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product Portfolio
  30. 6.5.5 Reata Pharmaceuticals, Inc. Recent Developments
  31. 6.6 Phenex Pharmaceuticals AG
  32. 6.6.1 Phenex Pharmaceuticals AG Company Information
  33. 6.6.2 Phenex Pharmaceuticals AG Business Overview
  34. 6.6.3 Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Product Portfolio
  36. 6.6.5 Phenex Pharmaceuticals AG Recent Developments
  37. 6.7 Nuevolution AB
  38. 6.7.1 Nuevolution AB Company Information
  39. 6.7.2 Nuevolution AB Business Overview
  40. 6.7.3 Nuevolution AB Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Nuevolution AB Nuclear Receptor ROR-Gamma Product Portfolio
  42. 6.7.5 Nuevolution AB Recent Developments
  43. 6.8 Lead Pharma Holding B.V.
  44. 6.8.1 Lead Pharma Holding B.V. Company Information
  45. 6.8.2 Lead Pharma Holding B.V. Business Overview
  46. 6.8.3 Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Product Portfolio
  48. 6.8.5 Lead Pharma Holding B.V. Recent Developments
  49. 6.9 Karo Bio AB
  50. 6.9.1 Karo Bio AB Company Information
  51. 6.9.2 Karo Bio AB Business Overview
  52. 6.9.3 Karo Bio AB Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Karo Bio AB Nuclear Receptor ROR-Gamma Product Portfolio
  54. 6.9.5 Karo Bio AB Recent Developments
  55. 6.10 Hanmi Pharmaceuticals, Co. Ltd.
  56. 6.10.1 Hanmi Pharmaceuticals, Co. Ltd. Company Information
  57. 6.10.2 Hanmi Pharmaceuticals, Co. Ltd. Business Overview
  58. 6.10.3 Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Product Portfolio
  60. 6.10.5 Hanmi Pharmaceuticals, Co. Ltd. Recent Developments
  61. 6.11 GlaxoSmithKline Plc
  62. 6.11.1 GlaxoSmithKline Plc Company Information
  63. 6.11.2 GlaxoSmithKline Plc Business Overview
  64. 6.11.3 GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Product Portfolio
  66. 6.11.5 GlaxoSmithKline Plc Recent Developments
  67. 6.12 Genfit SA
  68. 6.12.1 Genfit SA Company Information
  69. 6.12.2 Genfit SA Business Overview
  70. 6.12.3 Genfit SA Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Genfit SA Nuclear Receptor ROR-Gamma Product Portfolio
  72. 6.12.5 Genfit SA Recent Developments
  73. 6.13 Genentech, Inc.
  74. 6.13.1 Genentech, Inc. Company Information
  75. 6.13.2 Genentech, Inc. Business Overview
  76. 6.13.3 Genentech, Inc. Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Genentech, Inc. Nuclear Receptor ROR-Gamma Product Portfolio
  78. 6.13.5 Genentech, Inc. Recent Developments
  79. 6.14 Celgene Corporation
  80. 6.14.1 Celgene Corporation Company Information
  81. 6.14.2 Celgene Corporation Business Overview
  82. 6.14.3 Celgene Corporation Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Celgene Corporation Nuclear Receptor ROR-Gamma Product Portfolio
  84. 6.14.5 Celgene Corporation Recent Developments
  85. 6.15 Bristol-Myers Squibb Company
  86. 6.15.1 Bristol-Myers Squibb Company Company Information
  87. 6.15.2 Bristol-Myers Squibb Company Business Overview
  88. 6.15.3 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Product Portfolio
  90. 6.15.5 Bristol-Myers Squibb Company Recent Developments
  91. 6.16 Brickell Biotech, Inc.
  92. 6.16.1 Brickell Biotech, Inc. Company Information
  93. 6.16.2 Brickell Biotech, Inc. Business Overview
  94. 6.16.3 Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Product Portfolio
  96. 6.16.5 Brickell Biotech, Inc. Recent Developments
  97. 6.17 Biogen, Inc.
  98. 6.17.1 Biogen, Inc. Company Information
  99. 6.17.2 Biogen, Inc. Business Overview
  100. 6.17.3 Biogen, Inc. Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Biogen, Inc. Nuclear Receptor ROR-Gamma Product Portfolio
  102. 6.17.5 Biogen, Inc. Recent Developments
  103. 6.18 Aurigene Discovery Technologies Limited
  104. 6.18.1 Aurigene Discovery Technologies Limited Company Information
  105. 6.18.2 Aurigene Discovery Technologies Limited Business Overview
  106. 6.18.3 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Product Portfolio
  108. 6.18.5 Aurigene Discovery Technologies Limited Recent Developments
  109. 6.19 Arrien Pharmaceuticals, LLC
  110. 6.19.1 Arrien Pharmaceuticals, LLC Company Information
  111. 6.19.2 Arrien Pharmaceuticals, LLC Business Overview
  112. 6.19.3 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Product Portfolio
  114. 6.19.5 Arrien Pharmaceuticals, LLC Recent Developments
  115. 6.20 Advinus Therapeutics Ltd.
  116. 6.20.1 Advinus Therapeutics Ltd. Company Information
  117. 6.20.2 Advinus Therapeutics Ltd. Business Overview
  118. 6.20.3 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Product Portfolio
  120. 6.20.5 Advinus Therapeutics Ltd. Recent Developments
7 North America
  1. 7.1 North America Nuclear Receptor ROR-Gamma Market Size (2021-2032)
  2. 7.2 North America Nuclear Receptor ROR-Gamma Market Size by Type
  3. 7.2.1 North America Nuclear Receptor ROR-Gamma Market Size by Type (2021-2026)
  4. 7.2.2 North America Nuclear Receptor ROR-Gamma Market Size by Type (2027-2032)
  5. 7.2.3 North America Nuclear Receptor ROR-Gamma Market Share by Type (2021-2032)
  6. 7.3 North America Nuclear Receptor ROR-Gamma Market Size by Application
  7. 7.3.1 North America Nuclear Receptor ROR-Gamma Market Size by Application (2021-2026)
  8. 7.3.2 North America Nuclear Receptor ROR-Gamma Market Size by Application (2027-2032)
  9. 7.3.3 North America Nuclear Receptor ROR-Gamma Market Share by Application (2021-2032)
  10. 7.4 North America Nuclear Receptor ROR-Gamma Market Size by Country
  11. 7.4.1 North America Nuclear Receptor ROR-Gamma Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Nuclear Receptor ROR-Gamma Market Size by Country (2021-2026)
  13. 7.4.3 North America Nuclear Receptor ROR-Gamma Market Size by Country (2027-2032)
  14. 7.4.4 North America Nuclear Receptor ROR-Gamma Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Nuclear Receptor ROR-Gamma Market Size (2021-2032)
  2. 8.2 Europe Nuclear Receptor ROR-Gamma Market Size by Type
  3. 8.2.1 Europe Nuclear Receptor ROR-Gamma Market Size by Type (2021-2026)
  4. 8.2.2 Europe Nuclear Receptor ROR-Gamma Market Size by Type (2027-2032)
  5. 8.2.3 Europe Nuclear Receptor ROR-Gamma Market Share by Type (2021-2032)
  6. 8.3 Europe Nuclear Receptor ROR-Gamma Market Size by Application
  7. 8.3.1 Europe Nuclear Receptor ROR-Gamma Market Size by Application (2021-2026)
  8. 8.3.2 Europe Nuclear Receptor ROR-Gamma Market Size by Application (2027-2032)
  9. 8.3.3 Europe Nuclear Receptor ROR-Gamma Market Share by Application (2021-2032)
  10. 8.4 Europe Nuclear Receptor ROR-Gamma Market Size by Country
  11. 8.4.1 Europe Nuclear Receptor ROR-Gamma Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Nuclear Receptor ROR-Gamma Market Size by Country (2021-2026)
  13. 8.4.3 Europe Nuclear Receptor ROR-Gamma Market Size by Country (2027-2032)
  14. 8.4.4 Europe Nuclear Receptor ROR-Gamma Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Nuclear Receptor ROR-Gamma Market Size (2021-2032)
  2. 9.2 China Nuclear Receptor ROR-Gamma Market Size by Type
  3. 9.2.1 China Nuclear Receptor ROR-Gamma Market Size by Type (2021-2026)
  4. 9.2.2 China Nuclear Receptor ROR-Gamma Market Size by Type (2027-2032)
  5. 9.2.3 China Nuclear Receptor ROR-Gamma Market Share by Type (2021-2032)
  6. 9.3 China Nuclear Receptor ROR-Gamma Market Size by Application
  7. 9.3.1 China Nuclear Receptor ROR-Gamma Market Size by Application (2021-2026)
  8. 9.3.2 China Nuclear Receptor ROR-Gamma Market Size by Application (2027-2032)
  9. 9.3.3 China Nuclear Receptor ROR-Gamma Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Nuclear Receptor ROR-Gamma Market Size (2021-2032)
  2. 10.2 Asia Nuclear Receptor ROR-Gamma Market Size by Type
  3. 10.2.1 Asia Nuclear Receptor ROR-Gamma Market Size by Type (2021-2026)
  4. 10.2.2 Asia Nuclear Receptor ROR-Gamma Market Size by Type (2027-2032)
  5. 10.2.3 Asia Nuclear Receptor ROR-Gamma Market Share by Type (2021-2032)
  6. 10.3 Asia Nuclear Receptor ROR-Gamma Market Size by Application
  7. 10.3.1 Asia Nuclear Receptor ROR-Gamma Market Size by Application (2021-2026)
  8. 10.3.2 Asia Nuclear Receptor ROR-Gamma Market Size by Application (2027-2032)
  9. 10.3.3 Asia Nuclear Receptor ROR-Gamma Market Share by Application (2021-2032)
  10. 10.4 Asia Nuclear Receptor ROR-Gamma Market Size by Country
  11. 10.4.1 Asia Nuclear Receptor ROR-Gamma Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Nuclear Receptor ROR-Gamma Market Size by Country (2021-2026)
  13. 10.4.3 Asia Nuclear Receptor ROR-Gamma Market Size by Country (2027-2032)
  14. 10.4.4 Asia Nuclear Receptor ROR-Gamma Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Nuclear Receptor ROR-Gamma Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Nuclear Receptor ROR-Gamma Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Nuclear Receptor ROR-Gamma Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Nuclear Receptor ROR-Gamma Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst